The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules
Open accessAbstract
Long chain fatty acids have recently been identified as agonists for the G protein‐coupled receptors GPR40 and GPR120. Here, we present the first description of GW9508, a small‐molecule agonist of the fatty acid receptors GPR40 and GPR120. In addition, we also describe the pharmacology of GW1100, a selective GPR40 antagonist. These molecules were used to further investigate the role of GPR40 in glucose‐stimulated insulin secretion in the MIN6 mouse pancreatic β‐cell line. GW9508 and linoleic acid both stimulated intracellular Ca 2+ mobilization in human embryonic kidney (HEK)293 cells expressing GPR40 (pEC 50 values of 7.32±0.03 and 5.65±0.06, respectively) or GPR120 (pEC 50 values of 5.46±0.09 and 5.89±0.04, respectively), but not in the parent HEK‐293 cell line. GW1100 dose dependently inhibited GPR40‐mediated Ca 2+ elevations stimulated by GW9508 and linoleic acid (pIC 50 values of 5.99±0.03 and 5.99±0.06, respectively). GW1100 had no effect on the GPR120‐mediated stimulation of intracellular Ca 2+ release produced by either GW9508 or linoleic acid. GW9508 dose dependently potentiated glucose‐stimulated insulin secretion in MIN6 cells, but not in primary rat or mouse islets. Furthermore, GW9508 was able to potentiate the KCl‐mediated increase in insulin secretion in MIN6 cells. The effects of GW9508 on insulin secretion were reversed by GW1100, while linoleic acid‐stimulated insulin secretion was partially attenuated by GW1100. These results add further evidence to a link between GPR40 and the ability of fatty acids to acutely potentiate insulin secretion and demonstrate that small‐molecule GPR40 agonists are glucose‐sensitive insulin secretagogues. British Journal of Pharmacology (2006) 148, 619–628. doi:10.1038/sj.bjp.0706770
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ashburner, M. (1989) · Cold Spring Harbor Laboratory eBooks · Cited by 6,756
Brown, A. J., Goldsworthy, S. M., Barnes, A. A., Eilert, M. M., Tcheang, L., Daniels, D., Muir, A. I., Wigglesworth, M. J., Kinghorn, I., Fraser, N. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211609200 · Cited by 2,409
Self-citationLe Poul, E., Loison, C., Struyf, S., Springael, J.-Y., Lannoy, V., Decobecq, M.-E., Brezillon, S., Dupriez, V., Vassart, G., Van Damme, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301403200 · Cited by 1,651
Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120
Hirasawa, A., Tsumaya, K., Awaji, T., Katsuma, S., Adachi, T., Yamada, M., Sugimoto, Y., Miyazaki, S., & Tsujimoto, G. (2005) · Nature Medicine · doi:10.1038/nm1168 · Cited by 1,545
Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40
Itoh, Y., Kawamata, Y., Harada, M., Kobayashi, M., Fujii, R., Fukusumi, S., Ogi, K., Hosoya, M., Tanaka, Y., Uejima, H., et al. (2003) · Nature · doi:10.1038/nature01478 · Cited by 1,538
MIYAZAKI, J.-I., ARAKI, K., YAMATO, E., IKEGAMI, H., ASANO, T., SHIBASAKI, Y., OKA, Y., & YAMAMURA, K.-I. (1990) · Endocrinology · doi:10.1210/endo-127-1-126 · Cited by 1,266
The Orphan G Protein-coupled Receptor GPR40 Is Activated by Medium and Long Chain Fatty Acids
Briscoe, C. P., Tadayyon, M., Andrews, J. L., Benson, W. G., Chambers, J. K., Eilert, M. M., Ellis, C., Elshourbagy, N. A., Goetz, A. S., Minnick, D. T., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211495200 · Cited by 1,104
Self-citationOperational models of pharmacological agonism
Black, J. W., & Leff, P. (1983) · Proceedings of the Royal Society of London. Series B. Biological Sciences · doi:10.1098/rspb.1983.0093 · Cited by 951
Luckow, V. A., Lee, S. C., Barry, G. F., & Olins, P. O. (1993) · Journal of Virology · doi:10.1128/jvi.67.8.4566-4579.1993 · Cited by 912
Göttlicher, M., Widmark, E., Li, Q., & Gustafsson, J. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4653 · Cited by 857
Nilsson, N. E., Kotarsky, K., Owman, C., & Olde, B. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00488-1 · Cited by 540
Prentki, M., Vischer, S., Glennon, M. C., Regazzi, R., Deeney, J. T., & Corkey, B. E. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42624-5 · Cited by 442
Steneberg, P., Rubins, N., Bartoov-Shifman, R., Walker, M. D., & Edlund, H. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.03.007 · Cited by 411
Lipoapoptosis: its mechanism and its diseases
Unger, R. H., & Orci, L. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00342-6 · Cited by 361
Stein, D. T., Stevenson, B. E., Chester, M. W., Basit, M., Daniels, M. B., Turley, S. D., & McGarry, J. D. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119546 · Cited by 352
A human cell surface receptor activated by free fatty acids and thiazolidinedione drugs
Kotarsky, K., Nilsson, N. E., Flodgren, E., Owman, C., & Olde, B. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)03064-4 · Cited by 352
Ehlert, F. J. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13145-3 · Cited by 351
Haga, H., Yamada, R., Ohnishi, Y., Nakamura, Y., & Tanaka, T. (2002) · Journal of Human Genetics · doi:10.1007/s100380200092 · Cited by 304
A Role for Malonyl-CoA in Glucose-Stimulated Insulin Secretion from Clonal Pancreatic β-Cells
Corkey, B. E., Glennon, M. C., Chen, K. S., Deeney, J. T., Matschinsky, F. M., & Prentki, M. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)88227-1 · Cited by 265
Fujiwara, K., Maekawa, F., & Yada, T. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00035.2005 · Cited by 253
Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro
Parkes, D. G., Pittner, R., Jodka, C., Smith, P., & Young, A. (2001) · Metabolism · doi:10.1053/meta.2001.22519 · Cited by 241
Dobbins, R. L., Chester, M. W., Daniels, M. B., McGarry, J. D., & Stein, D. T. (1998) · Diabetes · doi:10.2337/diabetes.47.10.1613 · Cited by 230
Role of GPR40 in fatty acid action on the β cell line INS-1E
Shapiro, H., Shachar, S., Sekler, I., Hershfinkel, M., & Walker, M. D. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.042 · Cited by 220 · cited 4×
“…an increase in [Ca2þ ]i and insulin secretion, mediated via activation of phospholipase C (PLC) resulting in the release of calcium from the endoplasmic reticulum and upregulation of calcium influx via L-type calcium channels preactivated by glucose ((Fujiwara et al., 2005; Shapiro et al., 2005).”
BackgroundResultInfluentialTSUBOI, T., SILVA XAVIER, G. D., HOLZ, G. G., JOUAVILLE, L. S., THOMAS, A. P., & RUTTER, G. A. (2003) · Biochemical Journal · doi:10.1042/bj20021288 · Cited by 216
Sawzdargo, M., George, S. R., Nguyen, T., Xu, S., Kolakowski, L. F., & O'dowd, B. F. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7513 · Cited by 207
Warnotte, C., Gilon, P., Nenquin, M., & Henquin, J.-C. (1994) · Diabetes · doi:10.2337/diab.43.5.703 · Cited by 206
A Family of Fatty Acid Binding Receptors
Brown, A. J., Jupe, S., & Briscoe, C. P. (2005) · DNA and Cell Biology · doi:10.1089/dna.2005.24.54 · Cited by 170
Self-citationSignal transduction mechanisms in nutrient-induced insulin secretion
Prentki, M., Tornheim, K., & Corkey, B. E. (1997) · Diabetologia · doi:10.1007/s001250051395 · Cited by 164
Dobbins, R. L., Chester, M. W., Stevenson, B. E., Daniels, M. B., Stein, D. T., & McGarry, J. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1813 · Cited by 161
Salehi, A., Flodgren, E., Nilsson, N. E., Jimenez-Feltstrom, J., Miyazaki, J., Owman, C., & Olde, B. (2005) · Cell and Tissue Research · doi:10.1007/s00441-005-0017-z · Cited by 150
Acute effects of fatty acids on insulin secretion from rat and human islets of Langerhans
Gravena, C., Mathias, P. C. D. F., & Sj, A. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1730073 · Cited by 149
Reduction in Voltage-Gated K+ Currents in Primary Cultured Rat Pancreatic β-Cells by Linoleic Acids
Feng, D. D., Luo, Z., Roh, S.-G., Hernandez, M., Tawadros, N., Keating, D. J., & Chen, C. (2006) · Endocrinology · doi:10.1210/en.2005-0225 · Cited by 124
Olofsson, C. S., Salehi, A., Holm, C., & Rorsman, P. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.066258 · Cited by 88 · cited 5×
“Olofsson et al. (2004) demonstrated that 500 mM palmitate was able to potentiate whole-cell peak Ca2þ currents stimulated by 30mM KCl and that this effect appeared to be specific to L-type Ca2þ channels.”
BackgroundInfluentialQuantitative Trait Linkage Analysis of Lipid-Related Traits in Familial Type 2 Diabetes
Elbein, S. C., & Hasstedt, S. J. (2002) · Diabetes · doi:10.2337/diabetes.51.2.528 · Cited by 88
Hamid, Y. H., Vissing, H., Holst, B., Urhammer, S. A., Pyke, C., Hansen, S. K., Glümer, C., Borch‐Johnsen, K., Jørgensen, T., Schwartz, T. W., et al. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01505.x · Cited by 56
Ogawa, T., Hirose, H., Miyashita, K., Saito, I., & Saruta, T. (2005) · Metabolism · doi:10.1016/j.metabol.2004.09.008 · Cited by 49
Lehtihet, M., Welsh, N., Berggren, P., Cook, G. A., & Sjöholm, Å. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00057.2003 · Cited by 44
Palmitate-induced Ca2+-signaling in pancreatic beta-cells
Remizov, O., Jakubov, R., Düfer, M., Krippeit Drews, P., Drews, G., Waring, M., Brabant, G., Wienbergen, A., Rustenbeck, I., & Schöfl, C. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.09.026 · Cited by 41
Heterologous Expression of G Protein?Coupled Receptors in U-2 OS Osteosarcoma Cells
Ames, R. S., Nuthulaganti, P., Fornwald, J., Shabon, U., Keyl, H. V. D., & Elshourbagy, N. A. (2004) · Receptors and Channels · doi:10.1080/10606820490515012 · Cited by 31
Self-citation
Cited by
Oh, D. Y., Talukdar, S., Bae, E. J., Imamura, T., Morinaga, H., Fan, W., Li, P., Lu, W. J., Watkins, S. M., & Olefsky, J. M. (2010) · Cell · doi:10.1016/j.cell.2010.07.041 · Cited by 2,428
“However, this compound was not specific and also stimulated GPR120 (Briscoe et al., 2006).”
Free Fatty Acid Receptors in Health and Disease
Kimura, I., Ichimura, A., Ohue-Kitano, R., & Igarashi, M. (2020) · Physiological Reviews · doi:10.1152/physrev.00041.2018 · Cited by 1,018
Yan, Y., Jiang, W., Spinetti, T., Tardivel, A., Castillo, R., Bourquin, C., Guarda, G., Tian, Z., Tschopp, J., & Zhou, R. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.015 · Cited by 784
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes
Ahrén, B. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2782 · Cited by 419
Metadata
- Authors
- Briscoe, C. P., Peat, A. J., McKeown, S. C., Corbett, D. F., Goetz, A. S., Littleton, T. R., McCoy, D. C., Kenakin, T. P., Andrews, J. L., Ammala, C., Fornwald, J. A., Ignar, D. M., & Jenkinson, S.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2006-07
- Volume
- 148
- Issue
- 5
- Pages
- 619-628
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2089540591
- Cited by
- 400
- References
- 39
- FWCI
- 16.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.